Cargando…

Response to “Lactation Status and Studies of Pyrimethamine Pharmacokinetics in Pregnancy”

Detalles Bibliográficos
Autores principales:	de Kock, Miné, Tarning, Joel, Barnes, Karen I., Denti, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702899/ https://www.ncbi.nlm.nih.gov/pubmed/29052341 http://dx.doi.org/10.1002/psp4.12256

Ejemplares similares

Regarding “Lactation Status and Studies of Pyrimethamine Pharmacokinetics in Pregnancy”
por: Salman, Sam, et al.
Publicado: (2017)

Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery
por: de Kock, M, et al.
Publicado: (2017)

Erratum: Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery
por: de Kock, M., et al.
Publicado: (2020)

Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria
por: de Kock, Miné, et al.
Publicado: (2018)

Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali
por: Tekete, Mamadou M, et al.
Publicado: (2011)

A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children
por: Sjögren, Erik, et al.
Publicado: (2021)

Erratum: Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery
Publicado: (2020)

Corrigendum: Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery
Publicado: (2021)

Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule()
por: Abrouk, Michael, et al.
Publicado: (2016)

Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures
por: Gilder, Mary Ellen, et al.
Publicado: (2018)

Response: Fospropofol: Pharmacokinetics?
por: Bengalorkar, Girish M, et al.
Publicado: (2012)

Time to take stock of Indian regulatory guidelines regarding drug use in pregnancy and lactation
por: Arora, Aashima, et al.
Publicado: (2019)

Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance
por: Sundararaman, Sesh A., et al.
Publicado: (2022)

Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali
por: Maiga, Hamma, et al.
Publicado: (2015)

Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing
por: Ali, Ali Mohamed, et al.
Publicado: (2018)

Response to considerations regarding Maximal Lactate Steady State determination before redefining the gold‐standard
por: Jones, Andrew M., et al.
Publicado: (2019)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
por: Deloron, Philippe, et al.
Publicado: (2010)

Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy
por: Gutman, Julie, et al.
Publicado: (2012)

Lactation and COVID-19 Infection
por: Kaur, Hardeep, et al.
Publicado: (2022)

The association between iron status and some immunological factors in the pregnancy
por: Sobhani, Seyed Alireza, et al.
Publicado: (2011)

Lactate dehydrogenase, COVID-19 and mortality
por: Bartziokas, Konstantinos, et al.
Publicado: (2021)

Lactate dehydrogenase, COVID-19 and mortality
por: Bartziokas, Konstantinos, et al.
Publicado: (2021)

Author response to comment on: Re-thinking benign inflammation of the lactating breast: Classification, prevention, and management
por: Douglas, Pamela
Publicado: (2023)

Fospropofol: Pharmacokinetics?
por: Mahajan, Bharti, et al.
Publicado: (2012)

Cariprazine pharmacokinetics
Publicado: (2022)

Intermittent presumptive treatment in pregnancy with sulfadoxine–pyrimethamine: a counter perspective
por: Nosten, Francois, et al.
Publicado: (2015)

Inequities in the use of sulphadoxine-pyrimethamine for malaria prophylaxis during pregnancy in Nigeria
por: Ndu, Anne, et al.
Publicado: (2020)

Changing the policy for intermittent preventive treatment with sulfadoxine–pyrimethamine during pregnancy in Malawi
por: Mwendera, Chikondi A., et al.
Publicado: (2017)

Response to “Phrase truncation in PubMed searches”
por: Duffy, Steven, et al.
Publicado: (2017)

In reply to the letter to the editor regarding "A neonatal case of cerebral venous sinus thrombosis with intrauterine onset after COVID-19 infection during pregnancy: Cause or coincidence?"
por: Ozdil, Mine, et al.
Publicado: (2023)

Acenocoumarol’s pharmacokinetic: linear or not?
por: Kumar, Parveen, et al.
Publicado: (2019)

Teenage Pregnancies in Nepal - The Problem Status and Socio-Legal Concerns – Letter to The Editor
por: Poudel, Ishan
Publicado: (2019)

Maternal selenium status in pregnancy, offspring glutathione peroxidase 4 genotype, and childhood asthma
por: Shaheen, Seif O., et al.
Publicado: (2015)

Re: Teenage Pregnancies in Nepal - The Problem Status and Socio-Legal Concerns – Letter to The Editor
por: Nepal, Samata, et al.
Publicado: (2019)

Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia
por: Tan, Kathrine R, et al.
Publicado: (2014)

Effectiveness of intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) in Ghana
por: Dosoo, David Kwame, et al.
Publicado: (2021)

The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics
por: van Hasselt, J G Coen, et al.
Publicado: (2012)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
por: Awab, Ghulam Rahim, et al.
Publicado: (2016)

Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia”
por: Piena, Marjanne A., et al.
Publicado: (2022)

Response to ‘Evaluation of modelling study shows limits of COVID-19 importing risk simulations in sub-Saharan Africa’ (Epidemiology and Infection – HYG-LE-10513-May-20)
por: Haider, Najmul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_73j4jrqdmckdbjf08qoctdvfk5